Global Infection Control Market, By Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others) – Industry Trends and Forecast to 2031.
Infection Control Market Analysis and Size
Healthcare-associated infections (HAIs) are a significant cause of mortality globally, claiming nearly 100,000 lives annually in the U.S. alone. Factors contributing to their prevalence include compromised patient immunity, inadequate infection control measures, and the presence of various pathogens in healthcare settings. Age and prolonged hospital stays further exacerbate the risk. To combat this, there's a growing emphasis on reducing surgical site infections (SSI) through stringent sterilization protocols. Consequently, the market for sterilization products, crucial for medical device sterilization, pharmaceuticals, and life sciences, is witnessing significant growth, contributing to overall infection control market expansion.
Global infection control market size was valued at USD 49.10 million in 2023 and is projected to reach USD 71.44 million by 2031, with a CAGR of 4.80% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-microbial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
3M (U.S.), STERIS. (U.S.), Getinge AB (Sweden), MATACHANA GROUP (Spain), Ecolab (U.S.), BELIMED, INC (Switzerland), Cardinal Health. (U.S.), Steelco S.p.A. (Italy), Reckitt Benckiser Group plc (U.K.), Stryker (U.S.), B. Braun SE (Germany), Covalon Technologies Ltd. (Canada), SKYTRON, LLC (U.S.), Olympus Corporation (Japan), COLTENE Group (Switzerland), Pal International (U.K.), MELAG Medizintechnik GmbH & Co. KG (Germany), Terragene (U.K.), The Clorox Company (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Viruses, bacteria, fungi, and parasites constitute the primary culprits behind infections, spanning various bodily systems such as the stomach, lungs, eyes, and skin, as well as sexually transmitted routes. This encompasses a spectrum of ailments, including gastrointestinal, respiratory, ocular, aural, hospital-acquired, and dermatological infections. Infection control, therefore, entails the systematic mitigation or eradication of pathogens to curb their dissemination within healthcare environments.
Infection Control Market Dynamics
Drivers
- Escalation in Hospital-Acquired Infections (HAIS) Raise the Demand for Infection Control Products
HAIs pose a significant threat to patient safety and healthcare systems worldwide, leading to increased healthcare costs and patient morbidity and mortality. As healthcare facilities strive to mitigate the risks associated with HAIs, there is a heightened emphasis on implementing robust infection control measures and protocols. This includes stringent sterilization practices, improved hygiene protocols, and the adoption of advanced disinfection technologies to curb the spread of pathogens within healthcare settings. The Centers for Disease Control and Prevention (CDC) reports that approximately 5% of hospitalized patients will acquire a nosocomial infection, also known as a hospital-acquired infection (HAI). These infections contribute to over 99,000 fatalities annually. Consequently, the demand for infection control products and solutions, such as disinfectants, sterilization equipment, and antimicrobial coatings, is witnessing a notable surge, driving market expansion.
- Growing Technological Advancements in Sterilization Equipment Offers Superior Performance
Technological innovations enhance the efficiency, speed, and efficacy of sterilization processes, crucial for mitigating the spread of pathogens in healthcare settings. From the integration of advanced materials to the incorporation of automation and robotics, modern sterilization equipment offers superior performance and reliability. Additionally, developments in low-temperature sterilization methods address the compatibility of sensitive medical devices. The continuous evolution and adoption of such cutting-edge sterilization technologies bolster infection prevention efforts and contribute to the expansion of the global infection control market.
The Ministry of Health and Population's second phase of Infection Control Initiatives in Egypt's nine governorates reflects a commitment to integrating modern sterilization technologies into healthcare facilities. Leveraging advanced equipment and methods, such as automation and low-temperature sterilization, these initiatives aim to enhance hygiene standards, curb infection transmission, and ultimately elevate public health outcomes in the region, aligning with global trends in infection prevention.
Opportunities
- Increasing Outsourcing of Sterilization Services Focuses on Core Operations
Healthcare facilities are opting to outsource sterilization processes to specialized service providers due to factors such as cost-effectiveness, regulatory compliance assurance, and access to advanced sterilization technologies. Outsourcing allows healthcare institutions to focus on core operations while leveraging the expertise and infrastructure of external sterilization service providers. This trend is particularly prominent in regions witnessing a surge in healthcare infrastructure development and stringent regulatory requirements, thereby propelling the demand for infection control solutions and services.
- Escalating Volume of Surgical Procedures Necessitates Stringent Infection Control Measures
Surgical interventions inherently expose patients to heightened infection risks, underscoring the critical need for effective infection control protocols. Healthcare providers are increasingly investing in comprehensive infection control solutions to mitigate the potential for surgical site infections (SSIs) and other healthcare-associated infections (HAIs). This trend is driving the growth of the infection control market, as hospitals and surgical centers prioritize the implementation of advanced sterilization techniques, stringent hygiene protocols, and innovative technologies to safeguard patient health and enhance surgical outcomes.
Restraints/Challenges
- High Implementation Costs Limits the Expansion of Infection Control Standards
The initial capital outlay for acquiring modern equipment and technologies can be prohibitive for many healthcare facilities, particularly those operating on limited budgets or in resource-constrained settings. Ongoing expenses related to maintenance, consumables, and staff training further contribute to the financial burden. This barrier to entry may result in disparities in infection control standards between well-funded institutions and those with fewer resources, potentially compromising public health outcomes.
- Regulatory Compliance Increases the Complexity in Infection Control Procedures
Meeting regulatory compliance often entails extensive testing, documentation, and validation processes, leading to delays in product development and market entry. Varying regulatory frameworks across different regions and countries add complexity and cost to manufacturers seeking global market access. Non-compliance risks penalties, product recalls, and damage to reputation, further impeding market growth.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2020, Getinge AB launched Superfast 20 indicators, enhancing patient safety with faster processing times. These indicators comply with ISO 11138 standards and work with various sterilization methods, augmenting Getinge's global market presence
- In June 2021, Nanosonics launched Nanosonics AuditPro, an innovative digital platform for infection prevention. This product integrates advanced technology to streamline healthcare facilities' infection control processes, promising heightened efficiency and effectiveness
- In August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY in the Asia Pacific region. This Biological Indicator/Process Challenge Device enhances sterilization validation, contributing to safer healthcare practices and bolstering ASP's regional market position
Infection Control Market Scope
The market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterilization Products
- Heat Sterilization Equipment
- Moist Heat Sterilization Equipment
- Dry Heat Sterilization Equipment
- Low-Temperature Sterilization Equipment
- Radiation Sterilization Equipment
- Cleaning and Disinfection Products
- Disinfector
- Washer Disinfector
- Flusher Disinfector
- Endoscopic Reprocessor Systems
- High-End Endoscopic Reprocessor Systems
- Mid-Range Endoscopic Reprocessor Systems
- Low-End Endoscopic Reprocessor Systems
- Personal Protective Barriers
- Endoscope Reprocessing Products
- Anti-Microbial Surfaces
- Other Infection Control Products
Application
- Surgical Instruments
- Endoscopes
- Ultrasound Probes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
End User
- Hospitals
- Clinics
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Laboratories
- Others
Infection Control Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America stands at the forefront of the global infection control market, propelled by the proactive initiatives of established industry players. The region's dominance is underscored by a consistent influx of strategic partnerships forged by key market stakeholders. These collaborations not only signify a commitment to innovation and promise to accelerate the growth trajectory of the infection control market in North America throughout the forecast period, solidifying its leading position in the global landscape.
The Asia-Pacific is expected to experience rapid growth in the global infection control market, primarily attributed to the proliferation of outsourcing organizations. This growth trajectory is fueled by heightened healthcare expenditure across the region, which is anticipated to continue driving demand for infection control measures. With an increasing incidence of healthcare-associated infections, there's a growing emphasis on stringent infection prevention protocols, further propelling market expansion in the Asia-Pacific region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Infection Control Market Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are
- 3M (U.S.)
- STERIS. (U.S.)
- Getinge AB (Sweden)
- MATACHANA GROUP (Spain)
- Ecolab (U.S.)
- BELIMED, INC (Switzerland)
- Cardinal Health. (U.S.)
- Steelco S.p.A. (Italy)
- Reckitt Benckiser Group plc (U.K.)
- Stryker (U.S.)
- B. Braun SE (Germany)
- Covalon Technologies Ltd. (Canada)
- SKYTRON, LLC (U.S.)
- Olympus Corporation (Japan)
- COLTENE Group (Switzerland)
- Pal International (U.K)
- MELAG Medizintechnik GmbH & Co. KG (Germany)
- Terragene (U.K.)
- The Clorox Company (U.S.)
SKU-